Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥8.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥247m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥373m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥240m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥730m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥370m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥238m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥362m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥174m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥517m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥258m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥174m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥258m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥11.4bnat 2023-09-30Cons.Assets
Total assets¥11.5bnat 2023-03-31Cons.Assets
Total assets¥11.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥7.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥3.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥3.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥1.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥153m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥772m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥406m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥53m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥76m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥283m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥676m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥516m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1372023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥87.022023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.892022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥203.312022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.52022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio32.6%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.2%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥239m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30−¥2m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥459m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2023-04-01 → 2023-09-30¥397m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2023-04-01 → 2023-09-30¥397m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2023-04-01 → 2023-09-30¥13m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥486m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥230m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30−¥55m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥601m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2022-04-01 → 2022-09-30¥194m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2022-04-01 → 2022-09-30¥194m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2022-04-01 → 2022-09-30¥11m
—segment totalrevenue2022-04-01 → 2022-09-30¥4.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥4.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥603m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 495
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant2845741000JPY
Noncurrent liabilitiesCurrentQuarterInstant2640524000JPY
LiabilitiesPrior1YearInstant7897906000JPY
LiabilitiesCurrentQuarterInstant7701669000JPY
Capital stockPrior1YearInstant643099000JPY
Capital stockCurrentQuarterInstant643099000JPY
Capital surplusPrior1YearInstant248362000JPY
Capital surplusCurrentQuarterInstant248362000JPY
Retained earningsPrior1YearInstant2306628000JPY
Retained earningsCurrentQuarterInstant2416960000JPY
Treasury stockPrior1YearInstant-40605000JPY
Treasury stockCurrentQuarterInstant-40620000JPY
Shareholders equityPrior1YearInstant3157485000JPY
Shareholders equityCurrentQuarterInstant3267802000JPY
Valuation difference on available for sale securitiesPrior1YearInstant108046000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant140015000JPY
Revaluation reserve for landPrior1YearInstant288295000JPY
Revaluation reserve for landCurrentQuarterInstant288295000JPY
Foreign currency translation adjustmentPrior1YearInstant27871000JPY
Foreign currency translation adjustmentCurrentQuarterInstant34376000JPY
Remeasurements of defined benefit plansPrior1YearInstant-4816000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-4490000JPY
Valuation and translation adjustmentsPrior1YearInstant419397000JPY
Valuation and translation adjustmentsCurrentQuarterInstant458197000JPY
Net assetsPrior1YearInstant3576883000JPY
Net assetsCurrentQuarterInstant3725999000JPY
Liabilities and net assetsPrior1YearInstant11474789000JPY
Liabilities and net assetsCurrentQuarterInstant11427669000JPY
Net salesPrior1YTDDuration4171072000JPY
Net salesCurrentYTDDuration3866268000JPY
Cost of salesPrior1YTDDuration3158552000JPY
Cost of salesCurrentYTDDuration2929870000JPY
Gross profitPrior1YTDDuration1012519000JPY
Gross profitCurrentYTDDuration936397000JPY
Selling general and administrative expensesPrior1YTDDuration639066000JPY
Selling general and administrative expensesCurrentYTDDuration688958000JPY
Operating incomePrior1YTDDuration373453000JPY
Operating incomeCurrentYTDDuration247439000JPY
Interest income noiPrior1YTDDuration7000JPY
Interest income noiCurrentYTDDuration200000JPY
Dividends income noiPrior1YTDDuration4966000JPY
Dividends income noiCurrentYTDDuration5259000JPY
Rent income noiPrior1YTDDuration6798000JPY
Rent income noiCurrentYTDDuration6798000JPY
Foreign exchange gains noiPrior1YTDDuration4527000JPY
Foreign exchange gains noiCurrentYTDDuration-JPY
Subsidy income noiPrior1YTDDuration17270000JPY
Subsidy income noiCurrentYTDDuration17025000JPY
Other noiPrior1YTDDuration3919000JPY
Other noiCurrentYTDDuration2670000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass